Medtronic's MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany
Shots:
- Medtronic reports that it has secured for its reimbursement for the MiniMed 670G insulin pump system with the German Federal Association of the Statutory Health Insurances (GKV-SV). The reimbursement agreement will be effective from Aug 29- 2019
- The granted reimbursement will increase the accessibility of Medtronic’s MiniMed 670G Insulin pump system to more patients with type 1 diabetes
- MiniMed 670G is the only commercially available technology that personalizes the delivery of basal insulin 24hrs. a day based on real-time insulin needs- maximizing Time in Range in patients with T1D
Click here to read full press release/ article | Ref: Medtronic | Image: Integrated Diabetes Services
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com